Company Filing History:
Years Active: 2006-2017
Title: Innovations of Zsolt Dombrády: A Trailblazer in Pharmaceutical Patents
Introduction
Zsolt Dombrády is a prominent inventor based in Budapest, Hungary, with a remarkable portfolio consisting of 10 patents. His work primarily focuses on novel pharmaceutical processes that contribute significantly to the medical field, showcasing his expertise and dedication to innovation.
Latest Patents
Among his latest contributions to the field are two notable patents:
1. **Process for the preparation of dronedarone by removal of hydroxyl group** - This invention relates to a novel process for preparing dronedarone, along with pharmaceutically acceptable salts, by removing the hydroxyl group. The resulting product is isolated, and if necessary, converted into a pharmaceutically acceptable salt.
2. **Process for the preparation of dronedarone by N-butylation** - This patent describes a compound of formula (II) and its salts, along with processes for the preparation of this compound and its pharmaceutically acceptable salts.
Career Highlights
Zsolt Dombrády has made significant strides in the pharmaceutical industry. He has worked with reputable companies such as Sanofi and Sanofi-Aventis, where he has honed his skills in pharmaceutical development and innovation. His contributions have been pivotal in advancing drug formulations and processes.
Collaborations
Throughout his career, Zsolt has had the opportunity to collaborate with esteemed professionals including Antal Friesz and Csaba Huszár. These collaborations have further enriched his perspective in the field and have led to innovative breakthroughs in his patent portfolio.
Conclusion
Zsolt Dombrády's innovative spirit and commitment to pharmaceutical development continue to leave a substantial impact. With a strong foundation of successful patents and collaborations, he remains a key figure in advancing medical science through his inventions. His work not only enhances therapeutic options but also sets a precedent for future innovations in pharmaceuticals.